FM basket · stock · inception 2026-07-04
Started with ₹10,00,000 · max 10% per position (10 slots).
An agent-run trading desk over Atlas’s ranks (forward-only).
Execution costs of ₹0 are already inside this curve. Realized tax (FIFO, STCG/LTCG netted per FY): ₹0 → post-tax total return 0.0% vs 0.0% pre-tax.
Two curves: With 10% stop (the live rule — exit any position that closes 10% below its entry) vs No stop. On this book the stop is a net win — it cuts drawdown and lifts return by cutting real losers early.
Survivor-only backtest. The universe is today’s Atlas-scored names applied backwards, so stocks that delisted or collapsed never appear. Real drawdowns would be worse — read these returns as an optimistic upper bound, not a promise.
Thick bar = this portfolio · thin bar = NIFTY 500 sector weight.
| Instrument | Sector | Qty | Avg cost | Last | Value | Weight | P&L | Comp | Tech | Flow | Val | RS 3M | EMA 50/200 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IPCALAB IPCA Laboratories Limited | Pharma | 58 | 1719.40 | 1959.10 | ₹1,13,628 | 17.0% | +13.9% | 85 | 90 | 42 | 12 | +14.3% | ✓/✓ |
| AJANTPHARM Ajanta Pharma Limited | Pharma | 29 | 3345.30 | 3513.60 | ₹1,01,894 | 15.2% | +5.0% | 84 | 88 | 50 | 10 | +13.9% | ✓/✓ |
| CRAFTSMAN Craftsman Automation Limited | Automobile | 9 | 10047.00 | 11297.00 | ₹1,01,673 | 15.2% | +12.4% | 91 | 95 | 50 | 0 | +21.4% | ✓/✓ |
| NUVAMA Nuvama Wealth Management Limited | Capital Markets | 53 | 1887.50 | 1832.40 | ₹97,117 | 14.5% | -2.9% | 96 | 100 | 60 | 15 | +14.6% | ✓/✓ |
| RRKABEL R R Kabel Limited | Capital Goods | 39 | 2432.40 | 2387.10 | ₹93,097 | 13.9% | -1.9% | 84 | 88 | 50 | 6 | +6.4% | ✗/✓ |
| EICHERMOT Eicher Motors Limited | Automobile | 12 | 7689.50 | 7672.00 | ₹92,064 | 13.8% | -0.2% | 84 | 88 | 50 | 14 | +4.4% | ✗/✓ |
| EXIDEIND Exide Industries Limited | Automobile | 108 | 447.85 | 425.75 | ₹45,981 | 6.9% | -4.9% | 85 | 88 | 60 | 14 | +5.9% | ✗/✓ |
| DIACABS Diamond Power Infrastructure Limited | Capital Goods | 12 | 328.50 | 323.97 | ₹3,888 | 0.6% | -1.4% | — | — | — | — | — | —/— |
| LLOYDSENGG LLOYDS ENGINEERING WORKS LIMITED | Capital Goods | 2 | 91.15 | 83.19 | ₹166 | 0.0% | -8.7% | 84 | 88 | 52 | 7 | +14.5% | ✗/✓ |
Tries to catch sectors early, as they turn from weak to strong.
₹6.69 lakh
▼ ₹3,31,316 (-33.1%) since it started with ₹10.00 lakh
2026-09-11: No changes this cycle — nothing looked worth acting on, so it held everything.
What it has learned from its own results
• Reject add‑on trades for any stock that shows a 5‑day decline exceeding 2% after a sector‑wide weakness signal (70% confidence)
• Buy pharma stocks that post‑turn exhibit a 5‑day price gain greater than 2% after a sector‑wide pullback (70% confidence)
• Reject add‑on entries for any stock that has already posted a 5‑day gain above 4% after an early sector turn, as such stocks tend to reverse shortly thereafter. (60% confidence)
• Enter short positions in capital‑goods stocks when the sector shows early weakness and the stock’s 5‑day price move after entry is a decline of at least 4%. (60% confidence)
• Align trade direction with sector momentum: buy when the sector is turning up, short when the sector shows early weakness (50% confidence)
• Reject add‑on entries for stocks that have already posted a 5‑day gain exceeding 5% after an early sector turn; such stocks often reverse shortly thereafter (50% confidence)
How good the desk’s past calls have been (checked 20 days later vs the market)
| Grouped by | Calls made | Beat the market | Average edge |
|---|---|---|---|
| strategy: rotation | 122 | 47% | +0.6% |
| sector: Pharma | 101 | 38% | +1.2% |
| sector: Healthcare | 63 | 56% | +1.5% |
| sector: Banking | 46 | 44% | -0.6% |
| sector: Capital Goods | 35 | 51% | +4.2% |
| sector: Automobile | 32 | 59% | +5.6% |
| sector: Capital Markets | 18 | 39% | -8.1% |
| sector: Energy | 14 | 36% | -5.7% |
| Date | Instrument | Side | Qty | Price | Value | Cost | Realized P&L | Days | Bucket | Tax | Conviction | Reason |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-08 | NEULANDLAB | sell | 1 | 22870.00 | ₹22,870 | ₹23.56 | ₹3,126 | 40 | stcg | ₹625.24 | — | |
| 2026-09-04 | ANANTRAJ | sell | 157 | 628.30 | ₹98,643 | ₹101.60 | ₹1,660 | 43 | stcg | ₹332.07 | — | |
| 2026-08-18 | RBLBANK | sell | 52 | 381.50 | ₹19,838 | ₹20.43 | ₹495 | 19 | stcg | ₹99.00 | — | |
| 2026-08-18 | MEDANTA | sell | 73 | 1415.10 | ₹1,03,302 | ₹106.40 | ₹4,449 | 42 | stcg | ₹889.84 | — | |
| 2026-08-18 | RAINBOW | sell | 69 | 1478.50 | ₹1,02,017 | ₹105.08 | ₹2,434 | 43 | stcg | ₹486.84 | — | |
| 2026-08-14 | LLOYDSENGG | buy | 2 | 91.15 | ₹182 | ₹0.22 | — | — | — | — | — |